Helix BioPharma Corp. (HBP: Quote, HBP.TO) Thursday reported a third-quarter loss of $2.87 million or $0.04 per share, compared to $2.88 million or $0.05 per share in the same period last year. The loss narrowed helped mainly by lower operating expenses.
Third-quarter revenues totaled $1.00 million, down 7.8 percent from $1.09 million last year.
Operating expenses for the quarter decreased to $3.89 million from $4.02 million last year.
Click here to receive FREE breaking news email alerts for Helix Biopharma Corp. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org